Cargando…
Survival rates of cancer patients with and without rheumatic disease: a retrospective cohort analysis
BACKGROUND: To compare the outcomes of gastric, colon, lung, and breast cancer patients with and without rheumatic diseases (RD). METHODS: This retrospective study compared the cancer survival rates of a cohort of 122 cancer patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE)...
Autores principales: | Park, Jin Kyun, Yang, Ji Ae, Ahn, Eun Young, Chang, Sung Hae, Song, Yeong Wook, Curtis, Jeffrey R., Lee, Eun Bong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942908/ https://www.ncbi.nlm.nih.gov/pubmed/27412038 http://dx.doi.org/10.1186/s12885-016-2444-5 |
Ejemplares similares
-
Comparison of cancer incidence among patients with rheumatic disease: a retrospective cohort study
por: Chang, Sung Hae, et al.
Publicado: (2014) -
Elevated Erythrocyte Sedimentation Rate Is Predictive of Interstitial Lung Disease and Mortality in Dermatomyositis: a Korean Retrospective Cohort Study
por: Go, Dong Jin, et al.
Publicado: (2016) -
Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids
por: Park, Jun Won, et al.
Publicado: (2018) -
Risk-benefit analysis of isoniazid monotherapy to prevent tuberculosis in patients with rheumatic diseases exposed to prolonged, high-dose glucocorticoids
por: Park, Jun Won, et al.
Publicado: (2020) -
Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids—clinical implication of primary prophylaxis using trimethoprim–sulfamethoxazole
por: Park, Jun Won, et al.
Publicado: (2019)